Expression of fibronectin splicing variants in organ transplantation: a differential pattern between rat cardiac allografts and isografts.

作者: J W Kupiec-Weglinski , L F Brown , J H Peters , A J Coito , L van de Water

DOI:

关键词:

摘要: Allograft rejection is associated with infiltration of inflammatory cells and deposition extracellular matrix proteins. The extent to which diversity in the regulates cell function transplants remains unclear. One group proteins, termed fibronectins (FNs), exhibits inherent as a consequence alternative splicing three segments: EIIIA, EIIIB, or V. Although EIIIA segment has documented functions mesenchymal differentiation, neither this nor EIIIB have been tested for effects specific leukocyte functions. By contrast, V region can include CS-1 leukocytes may adhere through alpha 4 beta 1 integrins. In study, we demonstrate that EIIIA+, EIIIB+, V+ FN variants are synthesized, primarily by macrophages distinct temporal spatial patterns two rat cardiac transplant models: either antigenic challenge, allografts, without isografts. ratio inclusion into increases day allografts isografts high until rejected (approximately 7 days) but falls normal levels tolerated (day 6). EIIIB+ ratios peak later than do EIIIA+ FNs 4). remain relatively low Interestingly, deposited prominently myocardium rejecting close association infiltrating leukocytes, expression prominent at sites infarction. these largely restricted epicardium lesser degree immediately adjacent CS-1+ increase 3 hours after transplantation particularly days before rejection. Our data suggest differential role effector provide foundation testing their on rationale FN-based therapeutics modulate allograft recipients.

参考文章(57)
Jeffrey L. Barnes, Ronda J. Mitchell, Ernestine S. Torres, John H. Peters, Expression of alternatively spliced fibronectin variants during remodeling in proliferate glomerulonephritis American Journal of Pathology. ,vol. 147, pp. 1361- 1371 ,(1995)
J. E. Schwarzbauer, R. S. Patel, D. Fonda, R. O. Hynes, Multiple sites of alternative splicing of the rat fibronectin gene transcript. The EMBO Journal. ,vol. 6, pp. 2573- 2580 ,(1987) , 10.1002/J.1460-2075.1987.TB02547.X
L. Zagachin, R. O. Hynes, R. B. Colvin, K. Nishikawa, J. H. Peters, V. Nickeleit, Embryonic fibronectin isoforms are synthesized in crescents in experimental autoimmune glomerulonephritis. American Journal of Pathology. ,vol. 147, pp. 965- 978 ,(1995)
R B Colvin, H F Dvorak, R A Clark, Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. Journal of Immunology. ,vol. 126, pp. 787- 793 ,(1981)
J W Kupiec-Weglinski, L Van de Water, L F Brown, J Binder, A J Coito, M de Sousa, Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats. Journal of Immunology. ,vol. 154, pp. 2949- 2958 ,(1995)
B. Logan, L. F. Brown, H. F. Dvorak, L. Lavigne, L. Van Der Water, D. Dubin, Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. American Journal of Pathology. ,vol. 142, pp. 793- 801 ,(1993)
J. L. Barnes, M. A. De la Garza, R. R. Hastings, Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis. American Journal of Pathology. ,vol. 145, pp. 585- 597 ,(1994)
C J Roberts, T M Birkenmeier, J J McQuillan, S K Akiyama, S S Yamada, W T Chen, K M Yamada, J A McDonald, Transforming growth factor beta stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. Journal of Biological Chemistry. ,vol. 263, pp. 4586- 4592 ,(1988) , 10.1016/S0021-9258(18)68822-2
R A Ignotz, T Endo, J Massagué, Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. Journal of Biological Chemistry. ,vol. 262, pp. 6443- 6446 ,(1987) , 10.1016/S0021-9258(18)48258-0